These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26264855)

  • 1. Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes.
    Fu J; Wei C; Lee K; Zhang W; He W; Chuang P; Liu Z; He JC
    J Am Soc Nephrol; 2016 Apr; 27(4):1006-14. PubMed ID: 26264855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.
    Wang Y; Niu A; Pan Y; Cao S; Terker AS; Wang S; Fan X; Toth CL; Ramirez Solano MA; Michell DL; Contreras D; Allen RM; Zhu W; Sheng Q; Fogo AB; Vickers KC; Zhang MZ; Harris RC
    Diabetes; 2021 Oct; 70(10):2377-2390. PubMed ID: 34233930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.
    Srivastava SP; Zhou H; Setia O; Dardik A; Fernandez-Hernando C; Goodwin J
    J Am Heart Assoc; 2021 Aug; 10(15):e019437. PubMed ID: 34308664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
    Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
    Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
    Hartner A; Cordasic N; Menendez-Castro C; Volkert G; Yabu JM; Kupraszewicz-Hutzler M; Rascher W; Hilgers KF
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1151-7. PubMed ID: 20826576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.
    Zheng S; Carlson EC; Yang L; Kralik PM; Huang Y; Epstein PN
    J Am Soc Nephrol; 2008 Nov; 19(11):2077-85. PubMed ID: 18632844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.
    Sohn E; Kim J; Kim CS; Jo K; Kim JS
    Mol Med Rep; 2015 Oct; 12(4):5837-45. PubMed ID: 26299942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
    Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
    Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
    Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valsartan ameliorates podocyte loss in diabetic mice through the Notch pathway.
    Gao F; Yao M; Cao Y; Liu S; Liu Q; Duan H
    Int J Mol Med; 2016 May; 37(5):1328-36. PubMed ID: 26985716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease.
    Jung DS; Lee SH; Kwak SJ; Li JJ; Kim DH; Nam BY; Kang HY; Chang TI; Park JT; Han SH; Yoo TH; Kang SW
    Nephrol Dial Transplant; 2012 Jan; 27(1):259-66. PubMed ID: 21652547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorating effects of L-carnitine on diabetic podocyte injury.
    Fan JP; Kim D; Kawachi H; Ha TS; Han GD
    J Med Food; 2010 Dec; 13(6):1324-30. PubMed ID: 20946020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindin: a novel marker for podocyte injury in diabetic nephropathy.
    Murakoshi M; Tanimoto M; Gohda T; Hagiwara S; Takagi M; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2011 Jul; 26(7):2153-60. PubMed ID: 21098016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions.
    Zhou D; Zhou M; Wang Z; Fu Y; Jia M; Wang X; Liu M; Zhang Y; Sun Y; Zhou Y; Lu Y; Tang W; Yi F
    J Mol Med (Berl); 2019 Nov; 97(11):1507-1520. PubMed ID: 31402399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein-7 delays podocyte injury due to high glucose.
    De Petris L; Hruska KA; Chiechio S; Liapis H
    Nephrol Dial Transplant; 2007 Dec; 22(12):3442-50. PubMed ID: 17686813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.